FDA released patient and prescriber outreach materials to help promote understanding of biosimilars and interchangeable products.
Murilo Freitas - 16:44, 23 de May de 2018810
0
FDA offers a variety of patient and prescriber outreach materials, including graphics, drop-in content, and social media messages, to help promote understanding of biosimilars and interchangeable products: